Gain Therapeutics Inc. (GANX) NASDAQ
$3.19 (0.20) (-5.90%)
Market Cap: $51.74M
As of 04/24/24 04:00 PM EDT. Market closed.
Gain Therapeutics Inc. (GANX)
NASDAQ
$3.19
(0.20) (-5.90%)
Market Cap: $51.74M
As of 04/24/24 04:00 PM EDT. Market closed.
gain therapeutics is a preclinical stage biotech company specializing in the discovery of new drugs for orphan diseases. the company targets inborn errors of metabolism; a group of rare diseases of genetic origin with a high unmet medical need. gain therapeutics is also working on a new class of compounds: non-competitive pharmacological chaperones, identified through its innovative proprietary ... read more
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Riley Jeffrey Scott | Director | Mar 28, 2024 | Buy | $3.86 | 30,000 | 115,770 | 30,000 | Apr 01, 2024, 04:01 PM |
Alder Matthias | Chief Executive Officer | Mar 26, 2024 | Option Exercise | $4.06 | 6,085 | 24,705 | 21,140 | Mar 28, 2024, 09:00 PM |
Alder Matthias | Chief Executive Officer | Dec 21, 2023 | Sale | $2.46 | 206 | 507 | 5,286 | Dec 22, 2023, 04:17 PM |
Alder Matthias | Chief Executive Officer | Dec 07, 2023 | Sale | $2.50 | 1,820 | 4,550 | 4,855 | Dec 14, 2023, 04:01 PM |
RICHMAN ERIC I | CHIEF EXECUTIVE OFFICER | May 25, 2022 | Buy | $2.58 | 2,482 | 6,404 | 217,729 | May 27, 2022, 04:10 PM |
RICHMAN ERIC I | CHIEF EXECUTIVE OFFICER | May 20, 2022 | Buy | $2.83 | 9,256 | 26,194 | 215,247 | May 23, 2022, 04:41 PM |
RICHMAN ERIC I | CHIEF EXECUTIVE OFFICER | May 19, 2022 | Buy | $2.71 | 4,000 | 10,840 | 205,991 | May 23, 2022, 04:41 PM |
Calabrese Salvatore | CHIEF FINANCIAL OFFICER | May 19, 2022 | Buy | $2.70 | 3,000 | 8,100 | 3,000 | May 23, 2022, 04:00 PM |
Calabrese Salvatore | CHIEF FINANCIAL OFFICER | May 19, 2022 | Buy | $8100.00 | 3,000 | 24,300,000 | 8,100 | May 19, 2022, 05:00 PM |
RICHMAN ERIC I | Chief Executive Officer | Aug 16, 2021 | Buy | $7.87 | 4,922 | 38,716 | 216,820 | Apr 21, 2022, 04:50 PM |
RICHMAN ERIC I | Director | Aug 16, 2021 | Option Exercise | $7.87 | 4,922 | 38,716 | 216,820 | Aug 17, 2021, 09:03 PM |
Owner | Relationship | Date | Value($) |
Riley Jeffrey Scott | Director | 03/28/2024 | 115,770 |
Alder Matthias | Chief Executive Officer | 03/26/2024 | 24,705 |
Alder Matthias | Chief Executive Officer | 12/21/2023 | 507 |
Alder Matthias | Chief Executive Officer | 12/07/2023 | 4,550 |
RICHMAN ERIC I | CHIEF EXECUTIVE OFFICER | 05/25/2022 | 6,404 |
RICHMAN ERIC I | CHIEF EXECUTIVE OFFICER | 05/20/2022 | 26,194 |
RICHMAN ERIC I | CHIEF EXECUTIVE OFFICER | 05/19/2022 | 10,840 |
Calabrese Salvatore | CHIEF FINANCIAL OFFICER | 05/19/2022 | 8,100 |
Calabrese Salvatore | CHIEF FINANCIAL OFFICER | 05/19/2022 | 24,300,000 |
RICHMAN ERIC I | Chief Executive Officer | 08/16/2021 | 38,716 |
RICHMAN ERIC I | Director | 08/16/2021 | 38,716 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
GREENLIGHT CAPITAL INC | 588,410 | 0.09% | No change | Activists |
GEODE CAPITAL MANAGEMENT, LLC | 151,476 | 0.00005% | No change | Other |
RENAISSANCE TECHNOLOGIES LLC | 42,800 | 0.00022% | -8.74% | Other |
BLACKROCK INC. | 27,611 | 0% | -1.12% | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View